Published: 11 September 2022
BioAscent has launched Compound Connect, a web-based interface that provides customers with secure access to a customised, online inventory and ordering system helping them to manage their compound requirements and libraries.
BioAscent has a strong reputation for its big-pharma calibre compound management capabilities and expertise. With Compound Connect, our customers have the peace-of-mind that their compound inventory is up-to-date and trackable, and compounds can be accessed, ordered and delivered quickly and easily – something that is especially critical for innovative biotechs working with a network of CROs.
Compound Connect provides an easy-to-use and secure platform for customers to deposit details of compounds to be added to their inventory, as well as the ability to view their inventory easily, create orders and view the despatch history of their compounds.
Commenting, Sylviane Boucharens said: “Demand for our compound management services continues to grow, and new customers continue to entrust their compound management requirements to the team at BioAscent. We work with customers and customer libraries of all sizes, from start-up biotechs with a few tens of compounds, to well-established drug discovery companies with hundreds-of-thousands of compounds. Whatever the size of their library, the Compound Connect platform provides our customers with real-time access to their compound inventory and a simple approach to creating orders. Compound Connect is already saving customers time and effort, simplifying the management of their compounds and streamlining their drug discovery projects.”
The Compound Connect platform has been developed by the BioAscent Compound Management team and offers a fully auditable order fulfilment system that interfaces with the BioAscent Titian Mosaic compound management system and is also compatible with existing customer informatics systems.
To find out more about Compound Connect, and Compound Management services from BioAscent, get in touch.
Let's talk about how we can maximise your drug discovery success.